Literature DB >> 28159555

Different effects of G-protein-coupled receptor 120 (GPR120) and GPR40 on cell motile activity of highly migratory osteosarcoma cells.

Kaede Takahashi1, Kaori Fukushima1, Yuka Onishi1, Yusuke Node1, Karin Inui1, Nobuyuki Fukushima2, Kanya Honoki3, Toshifumi Tsujiuchi4.   

Abstract

G-protein-coupled receptor 120 (GPR120) and GPR40 are members of free fatty acid (FFA) receptors and mediate a variety of biological responses through binding of medium- and long-chain FFAs. Recently, it has been reported that GPR120 and GPR40 regulated cellular functions of cancer cells. In the present study, to assess whether GPR120 and GPR40 are involved in the enhancement of cell motile activity of osteosarcoma cells, we established highly migratory (MG63-R7) cells from osteosarcoma MG-63 cells. The expression level of GPR120 gene was significantly higher in MG63-R7 cells than in MG-63 cells, while no change of GPR40 expression was observed. In cell motility assay, the cell motile activity of MG63-R7 cells was approximately 200 times higher than that of MG-63 cells. The cell motile activity of MG63-R7 cells was stimulated by GW9508, which is an agonist of GPR120 and GPR40. Moreover, a GPR40 antagonist GW1100 elevated the cell motile activity of MG63-R7 cells in the presence of GW9508. To confirm the effects of GPR120 and GPR40 on the cell motile activity of MG63-R7 cells, GPR120 knockdown cells were generated from MG63-R7 cells. The cell motile activity of MG63-R7 cells was markedly suppressed by GPR120 knockdown. These results indicated that GPR120 enhanced and GPR40 inhibited the cell motile activity of highly migratory osteosarcoma cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell migration; GPR120; GPR40; Osteosarcoma cells

Mesh:

Substances:

Year:  2017        PMID: 28159555     DOI: 10.1016/j.bbrc.2017.01.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Serum Free Fatty Acids and G-Coupled Protein Receptors Are Associated With the Prognosis of Epithelial Ovarian Cancer.

Authors:  Lili Zhang; Xiangzhong Zhao; Huijun Chu; Han Zhao; Xiaoying Lai; Jing Li; Teng Lv
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 2.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

3.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

4.  Linoleic Acid Attenuates the Toxic Dose of Bupivacaine-Mediated Reduction of Vasodilation Evoked by the Activation of Adenosine Triphosphate-Sensitive Potassium Channels.

Authors:  Soo Hee Lee; Dawon Kang; Seong-Ho Ok; Seong-Chun Kwon; Hyun-Jin Kim; Eun-Jin Kim; Jeong-Min Hong; Ji-Yoon Kim; Sung Il Bae; Seungmin An; Ju-Tae Sohn
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

Review 5.  Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science.

Authors:  So-Eun Son; Nam-Jung Kim; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2021-01-01       Impact factor: 4.634

Review 6.  FFAR4: A New Player in Cardiometabolic Disease?

Authors:  Gage M Stuttgen; Daisy Sahoo
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.